According to ORIC Pharmaceuticals
's latest financial reports the company has โน17.53 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | โน21.95 B | 26.7% |
2023-12-31 | โน17.33 B | 1.54% |
2022-12-31 | โน17.06 B | -3.23% |
2021-12-31 | โน17.63 B | -17.85% |
2020-12-31 | โน21.47 B | 237.72% |
2019-12-31 | โน6.35 B | 113.27% |
2018-12-31 | โน2.98 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | โน17.53 B | 0.00% | ๐บ๐ธ USA |